M. JAMES BARRETT, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GLYCOMIMETICS INC

Filing Date Source Excerpt
2015-06-15 Dr. Barrett received a Ph.D. in biochemistry from the University of Tennessee, an M.B.A. from the University of Santa Clara and a B.S. from Boston College.
2016-04-11 Dr. Barrett received a Ph.D. in biochemistry from the University of Tennessee, an M.B.A. from the University of Santa Clara and a B.S. from Boston College.
2017-04-20 Dr. Barrett received a Ph.D. in biochemistry from the University of Tennessee, an M.B.A. from the University of Santa Clara and a B.S. from Boston College. The Board believes that Dr. Barrett’s experience overseeing NEA investments in biotechnology, serving as a member of the board of directors of other public companies, prior senior management experience, including as President and Chief Executive Officer of biopharmaceutical companies, and his strong capital markets experience allow him to make valuable contributions to the Board.
2018-04-13 Dr. Barrett received a Ph.D. in biochemistry from the University of Tennessee, an M.B.A. from the University of Santa Clara and a B.S. from Boston College. The Board believes that Dr. Barrett’s experience overseeing NEA investments in biotechnology... allow him to make valuable contributions to the Board.

GYRE THERAPEUTICS, INC.

Filing Date Source Excerpt
2012-04-20 M. James Barrett, Ph.D. ... Age 69 ... Position: Class II Director ... The current members of the Compensation Committee are Dr. Barrett, Ms. Brown, Dr. Dunton and Mr. Skaletsky ... 2011 DIRECTOR COMPENSATION TABLE ... M. James Barrett ... Total ($) 127,478
2013-04-17 M. James Barrett, Ph.D. ... The current members of the Governance and Nominating Committee are Mr. Blixt, Dr. De Souza, Mr. Skaletsky and Dr. Snyderman ... The current members of the Compensation Committee are Dr. Barrett, Ms. Brown, Dr. Dunton and Mr. Richard ... 2012 Director Compensation Table ... M. James Barrett ... Total ($) 50,475

SUPERNUS PHARMACEUTICALS, INC.

Filing Date Source Excerpt
2013-03-29 Dr. Barrett received a Ph.D. in Biochemistry at the University of Tennessee, his MBA from the University of Santa Clara, and a BS in Chemistry from Boston College.
2014-04-07 Dr. Barrett received a Ph.D. in Biochemistry at the University of Tennessee, his MBA from the University of Santa Clara, and a BS in Chemistry from Boston College. Dr. Barrett's substantial experience with public and private companies in the healthcare sector and his venture capital, financial and business experience qualify him to serve as a director.
2015-03-30 Dr. Barrett received a Ph.D. in Biochemistry at the University of Tennessee, his MBA from the University of Santa Clara, and a B.S. in Chemistry from Boston College. Dr. Barrett's substantial experience with public and private companies in the healthcare sector and his venture capital, financial and business experience qualify him to serve as a director.
2016-04-19 Dr. Barrett received a Ph.D. in Biochemistry at the University of Tennessee, his MBA from the University of Santa Clara, and a B.S. in Chemistry from Boston College.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-06